glp-1 drug liraglutide may protect against dementia FDA Approves Generic Version of Injection, a for Weight Loss GLP-1 Drug Fails to Quell
Description
A., & Tosti, A
Are there oral options for GLP-1 agonists
Its dosing regimen starts gradually, increasing over time to the full 2.4 mg maintenance dose
The various approaches include the combination of GLP-1R agonists with leptin [912,913], salmon calcitonin [914], PYY [915], CCK [916], insulin [917], adrenomedullin [918], and 3-adrenergic receptor agonists [919], and antagonists at the cannabinoid receptor 1 (CB1) [920], or agonists at the receptors for melanocortin-4 (MC4R) [685] or farnesoid-x (FXR) [921]
doi: 10.2337/db10-0103 66 SaundersALBodineCSnell-BergeonJForlenzaGPShahVN
the decision depends on your HbA1c, weight, and hypoglycemia history
